Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin

Int J Obes Relat Metab Disord. 2004 Jul;28(7):886-93. doi: 10.1038/sj.ijo.0802646.

Abstract

Objective: The role of the melanocortin system in the feeding effects of peripheral peptide YY(3-36) (PYY(3-36)) and ghrelin was investigated using the agouti (A(y)/a) mouse as a model of abnormal melanocortin signalling. Furthermore, we examined whether the ectopic expression of agouti protein in A(y)/a mice results in complete MC4-R inhibition, by studying the effects of peripheral alpha-melanocyte-stimulating hormone (alpha-MSH) and leptin on food intake.

Design: Adult A(y)/a mice were studied in the pre-obese state (7-8 weeks) and obese state (14-15 weeks). Animals received PYY(3-36) (0.02 micromol/kg), NDP-alpha-MSH (0.2 micromol/kg), leptin (2 micromol/kg) (all 24 h fasted state) and ghrelin (0.2 micromol/kg) (fed state) by intraperitoneal (i.p.) injection. Age-matched A(y)/a controls received i.p. saline. A separate cohort of wild-type (WT), age-matched controls received the same peptide dose or saline. Food intake was measured at 1, 2, 4, 8 and 24 h post-injection and compared in all four groups. Plasma leptin-, ghrelin- and PYY-like immunoreactivity (IR) were measured using radioimmunoassay (RIA).

Results: At 2 h post-injection, PYY(3-36) reduced food intake in pre-obese and obese A(y)/a mice, whereas ghrelin had no effect. Plasma ghrelin levels were significantly reduced in pre-obese and obese A(y)/a mice compared to WT controls. Peripheral administration of NDP-alpha-MSH and leptin acutely suppressed feeding (0-2 h) in pre-obese and obese A(y)/a mice.

Conclusions: Responsiveness of pre-obese and obese A(y)/a mice to PYY(3-36) suggests that the melanocortin system may not be essential for the anorectic effects of this peptide. Melanocortinergic antagonism by agouti protein in A(y)/a mice may be sufficient to block the effects of endogenous, but not exogenous PYY(3-36), alpha-MSH and leptin. The mechanism underlying ghrelin resistance in A(y)/a mice may result from antagonism of hypothalamic melanocortin receptors-4 by agouti protein, supporting a role for the melanocortin system in mediating ghrelin's actions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agouti Signaling Protein
  • Animals
  • Appetite / drug effects
  • Drug Resistance
  • Eating / drug effects*
  • Fasting
  • Ghrelin
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Leptin / blood
  • Leptin / pharmacology
  • Melanocyte-Stimulating Hormones / antagonists & inhibitors
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Mice, Transgenic
  • Obesity / blood
  • Obesity / physiopathology*
  • Peptide Fragments
  • Peptide Hormones / blood
  • Peptide Hormones / pharmacology*
  • Peptide YY / blood
  • Peptide YY / pharmacology*
  • Receptor, Melanocortin, Type 4 / genetics
  • Receptor, Melanocortin, Type 4 / physiology
  • alpha-MSH / pharmacology

Substances

  • Agouti Signaling Protein
  • Ghrelin
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Peptide Fragments
  • Peptide Hormones
  • Receptor, Melanocortin, Type 4
  • a protein, mouse
  • Peptide YY
  • peptide YY (3-36)
  • alpha-MSH
  • Melanocyte-Stimulating Hormones